(Q72390336)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6088747%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

title

Pharmacokinetics of ceftriaxone in neonates and infants with meningitis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6088747%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

1 reference

1 reference

1 reference

E. Martin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6088747

2 August 2023

J. R. Koup

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6088747

2 August 2023

U. Paravicini

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6088747

2 August 2023

K. Stoeckel

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6088747

2 August 2023

language of work or name

English

0 references

publication date

1 September 1984

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6088747%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

26 October 2019

https://api.elsevier.com/content/article/PII:S0022347684800323?httpAccept=text/xml

1 reference

10.1016/S0022-3476(84)80032-3

DOI

https://api.crossref.org/works/10.1016/S0022-3476(84)80032-3

https://api.elsevier.com/content/article/PII:S0022347684800323?httpAccept=text/plain

2 August 2023

1 reference

10.1016/S0022-3476(84)80032-3

DOI

https://api.crossref.org/works/10.1016/S0022-3476(84)80032-3

The Journal of Pediatrics

2 August 2023

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6088747%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

volume

105

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6088747%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6088747%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

page(s)

475-481

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6088747%20AND%20SRC:MED&resulttype=core&format=json

Antibacterial activity of ceftriaxone (Ro 13-9904), a beta-lactamase-stable cephalosporin

26 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2980032-3

In vitro activity of Ro 13-9904, a new beta-lactamase-stable cephalosporin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2980032-3

In vitro antibacterial activity and susceptibility of the cephalosporin Ro 13-9904 to beta-lactamases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2980032-3

Comparison of the efficacy and safety of ceftriaxone to ampicillin/ chloramphenicol in the treatment of childhood meningitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2980032-3

In vitro susceptibility of gram-negative bacilli from pediatric patients to moxalactam, cefotaxime, Ro 13-9904, and other cephalosporins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2980032-3

Pharmacokinetics and bacteriological efficacy of cefoperazone, ceftriaxone, and moxalactam in experimental Streptococcus pneumoniae and Haemophilus influenzae meningitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2980032-3

Pharmacokinetics and Bacteriologic Efficacy of Moxalactam, Cefotaxime, Cefoperazone, and Rocephin in Experimental Bacterial Meningitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2980032-3

Pharmacokinetics and cerebrospinal fluid bactericidal activity of ceftriaxone in the treatment of pediatric patients with bacterial meningitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2980032-3

Pharmacokinetics of Ceftriaxone in Pediatric Patients With Meningitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2980032-3

Single-dose ceftriaxone pharmacokinetics in pediatric patients with central nervous system infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2980032-3

Pharmacokinetics of Rocephin, a highly active new cephalosporin with an exceptionally long biological half-life

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2980032-3

Efficacy of ceftriaxone in treatment of serious childhood infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2980032-3

Multiple intravenous dose pharmacokinetics of ceftriaxone in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2980032-3

Single-dose pharmacokinetics of ceftriaxone in infants and young children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2980032-3

Ceftriaxone pharmacokinetics in newborn infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2980032-3

Effects of concentration-dependent plasma protein binding on ceftriaxone kinetics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2980032-3

Ceftriaxone diffusion into cerebrospinal fluid of children with meningitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2980032-3

Once-daily administration of ceftriaxone in the treatment of meningitis and other serious infections in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2980032-3

Ceftriaxone versus ampicillin and chloramphenicol for treatment of bacterial meningitis in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2980032-3

10.1016/S0022-3476(84)80032-3

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6088747%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

1 reference